Clinical Trial Search

Primary: Time to Initial Treatment Failure — 7.81; 19.97; 17.79; 34.67 Rate (%) — p=<0.001

Primary: Change in the Abundance of Staphylococcus Aureus in the Nose After Decolonization — -781 fg/uL

Primary: Complete Resection Rate — 161; 148; 6; 7 Participants — p=0.05

Primary: Number of Participants With HIV Viral Load < 40 Copies/ML at 1 Year — 52; 44 Participants — p=0.002

Primary: The Primary Safety Endpoint Included Any Death or Major Stroke in the First 30 Days and Neurologic Death or Ipsilateral Major Stroke Between Day 31 and Day 365. — 1…

Primary: Mean Change From Baseline in NRS Pain Score at 8 Hours After Dilator Insertion — 2; 2.5 Numeric rating scale pain score change

Primary: Creatinine Clearance (CrCl) in the Immediate Post-transplant Period — 5.11; 7.44; 6.30; 9.66 mL/min — p=0.9076

Primary: Effectiveness Will be Measured for AMERICAN SHOULDER AND ELBOW (ASES) Score — 66; 77 score on a scale — p=0.048

Primary: Radiographic Arthrodesis — 56 Participants

Primary: Cervix Elasticity — 54; 19.7 kPa

Primary: Cases of Kidney Transplant Patients With DSA — 0; 0 Participants

Primary: The Effects of Electrical Spinal Cord Stimulation (SCS) on Airway Pressure Generation While Using Temporarily Placed Parallel Wire Leads and Implanted Disc Electrodes…

Primary: Changes in Total-cholesterol Levels — -6.9; -0.6 mg/dl

Primary: Number of Participants With Drug-related Adverse Events (AEs) — 0 Participants

Primary: Acute Safety - Procedure Related SAEs From Randomization Through Discharge For Device Arm Only — 3; 1; 1; 3 events